浙江大学:《药理学》课程教学资源(PPT课件讲稿)神经系统药理学 Pharmacology of the nervous system(主讲:张世红)

Pharmacology of efferent nervous system Cholinergic Pharmacology Adrenergic Pharmacology 2
• Cholinergic Pharmacology • Adrenergic Pharmacology Pharmacology of efferent nervous system 2

AC ACh N Parasympathetic Medulla Cardiac and smooth muscle gland cells, nerve terminals Sympathetic ACh Sweat glands ACh NE Sympathetic Cardiac and smooth muscle gland cells, nerve terminals Spinal ACh Sympathetic Renal vascular smooth muscle ACh Epi, NE ACh Adrenal medulla Somatic Skeletal muscle Voluntary motor nerve Copyright @2006 by The McGraw-Hill Companies, Inc. All rights reserved
3

NE synthesis in nerve terminals and turnover 1 SYNTHESIS OF NH2 NOREPINEPHRINE CH.C-COOH he rate-limiting step 2 UPTAKE INTO STORAGE VESICLES H Inactive 4 e Dopamine entera vesicle L-Tyrosine e Norepinephrine is protected Tyrosine hydroxylase om degradation in erin, o Transport into vesicle is HO Inactive HO CH2C-COOH L-DOPA 3 RELEASE OF NEUROTRANSMITTER DOPA decarboxylase coll membrane ( Pyridoxal phosphate) e Release blocked by HO HO 5 REMOVAL OF NOREPINEPHRINE Dopamine rapidly taken into neuron Dopamine B-hydroxylase cocaine and imlpram (Ascorbate, O) 4 BINDING TO RECEPTOR of neurotransmitter 一CHCH2NH2 SYNAPTIC Norepinephrine 6 METABOLISM SPACE Catecholamine Biosynthetic Pathway mIne oxidase INTRACELLULAR RESPONSE
NE synthesis in nerve terminals and turnover Catecholamine Biosynthetic Pathway 4

NH2 Norepinephrine and Epinephrine CH2C-COOH L-Tyrosine Synthesis in the Adrenal Medulla Tyrosine hydroxylase (Tetrahydrobiopterin, O,) PNMT苯氨基乙醇N-甲基转移酶 is located in the NH2 CH2C-COOH cytosol L-DOPA DBH多巴脱羧酶 is located in vesicles DOPA decarboxylase EPl is stored in vesicles EPl(-80%)and NE(-20%)are released into blood CH, CH NH Dopamine Dopamine B-hydroxylase PNMI NE)→NE一→EPI→EPI (Ascorbate, O2 H CHCH2 NH2 Norepinephrine Chromaffin cell Phenylethanolamine N-methyltransferase (S-adenosylmethionine CHCH NHCH Epinephrine
Norepinephrine and Epinephrine Synthesis in the Adrenal Medulla - PNMT苯氨基乙醇N-甲基转移酶 is located in the cytosol - DBH 多巴脱羧酶 is located in vesicles - EPI is stored in vesicles. - EPI (~80%) and NE (~20%) are released into blood Chromaffin cell NE PNMT NE EPI EPI 5

Norepinephrine and epinephrine Metabolism MAO B2b28-=b MHPG(3甲氧4羟苯乙二醇 CH2-NH2 -CH2 was used as an index of cns ne turnover Norepinephrine DOPGAL Epinephrine but generated mostly from aldehyde COMT aldehyde reducts COMT periphery CH,O VMA(香草扁桃酸) sometimes used as an index of ne turnover Normetanephrine DOPEG DOMA Metanephrine Sulfate conjugates COMT COM also prevalent Elimination by kidneys MOPEG or MHPG VMA VMA Urine MHPG-SO NMN-SO reductase dehydrogenase MN-SO MAO Relative amounts excreted MOPGAL
Norepinephrine and Epinephrine Metabolism MHPG (3-甲氧4-羟苯乙二醇): was used as an index of CNS NE turnover but generated mostly from periphery VMA(香草扁桃酸): sometimes used as an index of NE turnover Sulfate conjugates also prevalent or MHPG 6

Adrenergic Receptor Subtypes &G-Protein Coupled Mechanisms a, Adrenergic Receptors Phospholipase C activation, IP3 increase through G Mechanism: mobilize and increase intracellular free calcium Effects: primarily smooth muscle contraction a2 Adrenergic Receptors: Inhibition of adenyl cyclase through G proteins Mechanism decrease intracellular camp levels Effects: decrease protein phosphorylation, decrease cellular function
1 Adrenergic Receptors: Phospholipase C activation, IP3 increase through Gq Mechanism: mobilize and increase intracellular free calcium Effects: primarily smooth muscle contraction 2 Adrenergic Receptors: Inhibition of adenyl cyclase through Gi proteins Mechanism: decrease intracellular cAMP levels Effects: decrease protein phosphorylation, decrease cellular function Adrenergic Receptor Subtypes & G-Protein Coupled Mechanisms 7

Adrenergic Receptor Subtypes &G-Protein Coupled Mechanisms B Adrenergic Receptors Activation of adenyl cyclase through Gs proteins Mechanism increase intracellular camP levels Effects: phosphorylation of intracellular proteins, smooth muscle relaxation cardiac muscle contraction
β Adrenergic Receptors: Activation of adenyl cyclase through Gs proteins Mechanism: increase intracellular cAMP levels Effects: phosphorylation of intracellular proteins, smooth muscle relaxation, cardiac muscle contraction Adrenergic Receptor Subtypes & G-Protein Coupled Mechanisms 8

Receptor 可乐定 Subtypes 去氧肾上腺素 <Clon he 异丙肾上腺素 a R(AC PLC 冷B DG 工 cAMP ⊙ 个cAMP 个Ca PKA)O P 9
q 去氧肾上腺素 异丙肾上腺素 可乐定 9

Four Major Activators of the Adrenergic System Hypoxia-response is mainly cardiovascular: increase in heart rate contractility(B1); vasodilation of blood vessels in muscle(β2) Hypoglycemia -response is mainly metabolic ( glycogenolysis 阝2anda1, gluconeogenesisβ2andc12, lipolysisβesp.β3, a2), but B2 vasodilation in muscle increases glucose delivery Hypothermia- piloerection( M), peripheral vasocontraction (Ol), thermogenesis(B) Hypotension-baroreceptor reflex 10
• Hypoxia - response is mainly cardiovascular: increase in heart rate & contractility (b1 ); vasodilation of blood vessels in muscle (b2 ). • Hypoglycemia - response is mainly metabolic (glycogenolysis b2 and 1 , gluconeogenesis b2 and 1,2, lypolysis b esp. b3 , 2 ), but b2 vasodilation in muscle increases glucose delivery. • Hypothermia - piloerection (M), peripheral vasocontraction (1 ), thermogenesis (b) • Hypotension – baroreceptor reflex Four Major Activators of the Adrenergic System 10

Summary: Adrenoceptors a receptors a, receptors: vasoconstriction: increased peripheral resistance, BP r, contraction of radial muscle of iris: mydriasis a2 receptors: CNS, presynaptic membranes of adrenergic nerves: vasodilatation inhibition of ne release inhibition of insulin release
receptors • 1 receptors: vasoconstriction: increased peripheral resistance, BP↑; contraction of radial muscle of iris: mydriasis • 2 receptors: CNS, presynaptic membranes of adrenergic nerves: vasodilatation, inhibition of NE release; inhibition of insulin release Summary: Adrenoceptors 11
按次数下载不扣除下载券;
注册用户24小时内重复下载只扣除一次;
顺序:VIP每日次数-->可用次数-->下载券;
- 中南民族大学:《药物分析实验》课程教学资源(PPT课件讲稿,共四个实验).ppt
- 《临床药理学》课程教学课件(PPT讲稿)老年人的药物治疗与常用药.ppt
- 被子植物门生药(PPT课件讲稿)百合科 Araceae、鸢尾科 Iriddaceae.ppt
- 《发酵制药》课程教学资源(PPT课件讲稿)放线菌发酵制药(链霉素发酵).ppt
- 山西医科大学:《生药学 Pharmacognosy》课程教学资源(PPT课件讲稿)第九章 动物生药(主讲教师:张琼).ppt
- 山西医科大学:《生药学 Pharmacognosy》课程教学资源(PPT课件讲稿)第一章 根及根茎类生药(2/2).ppt
- 西安交通大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)第四章 抗生素 Antibiotics.ppt
- 《药物合成反应》课程教学资源(PPT课件讲稿)第三章 酰化反应 Acylation Reaction.ppt
- 西安交通大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)第六章 氧化反应 Oxidation Reaction.ppt
- 《药学》课程教学资源(PPT讲稿)常用药物常识.pptx
- 《药物分析》课程教学资源(PPT课件讲稿)第三章 药物的杂质检查 Test for purity.ppt
- 长沙医学院:《药剂学》课程教学资源(PPT课件讲稿)第五章 固体制剂(胶囊剂、滴丸和膜剂).ppt
- 《药理学》课程PPT教学课件(讲稿)第二章 药物代谢动力学.ppt
- 中国医科大学:《药物毒理学》课程教学资源(PPT课件讲稿)第一章 总论(主讲:郝丽英).ppt
- 中国医科大学:《药理学》课程教学资源(PPT课件讲稿)激素类药物(主讲:李金鸣).ppt
- 四川大学:《药理学》课程教学资源(PPT课件讲稿)抗菌药概论(华西基础医学与法医学院:周黎明).pptx
- 《药理学》课程PPT教学课件(讲稿)第三章 药物效应动力学.ppt
- 河北医科大学:《药理学》课程教学资源(PPT课件)胰岛素及口服降血糖药——抗糖尿病药.ppt
- 《药理学》课程PPT教学课件(讲稿)第二章 药物代谢动力学 pharmacokinetics.ppt
- 长沙医学院:《药剂学》课程教学资源(PPT课件讲稿)第五章 药物代谢 Drug Metabolism.ppt
- 《药物分析》课程教学资源(PPT课件讲稿)第六章 芳酸及其酯类药物的分析.ppt
- 《天然药物化学》课程教学资源(PPT课件讲稿)第三十四章 人工合成抗菌药.ppt
- 《药理学》课程教学资源(PPT课件讲稿)第三十二章 抗菌药物概述.ppt
- 《药理学》课程教学资源(PPT课件讲稿)第二章 药物代谢动力学.ppt
- 武汉大学药学院博士课程:现代药学研究新进展(主讲:台万一).pdf
- 黑龙江八一家垦大学:动物药学专业就业分析(姚启程).pptx
- 《护理药理学》课程教学资源(PPT课件讲稿)课程介绍.ppt
- 复旦大学:《药理学》精品课程教学资源(习题)作业自测习题(含答案).docx
- 《药物设计学》课程教学资源(参考教材)计算机辅助药物设计导论(编著:叶德泳)An Introduction to Computer-Aided Drug Design.pdf
- 《药物设计学》课程教学资源(参考教材)医药化学(影印版)Medicinal Chemistry.pdf
- 《药物设计学》课程教学资源(参考教材)药物化学精览(中文本,著:[英]G.帕特里克,译:孙铁民、郭春).pdf
- 《药物设计学》课程教学资源(参考教材)药物设计与药物行为的有机化学(第二版)The Organic Chemistry of Drug Design and Drug Action.pdf
- 《药物设计学》课程教学资源(参考教材)国外药学专著译丛《有机药物化学》电子书(原著第二版,共八章,[美]R.B.西尔弗曼 Richard B. Silverman,主译:郭宗儒).pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-I HYDROPHOBICITY IN DRUG DESIGN.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-II COMPARING LOG P CALCULATIONS BY THE GHOSE–CRIPPEN AND VILLAR METHODS.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-III-1E STRUCTURAL DATA:THE BASIS FOR MOLECULAR MODELING.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-III-2E A LABORATORY COURSE IN MEDICINAL CHEMISTRY INTRODUCING MOLECULAR MODELING.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-III-4E MEDICINAL CHEMISTRY AND MOLECULAR MODELING:AN INTEGRATION FOR THE TEACHING OF DRUG STRUCTURE–ACTIVITY RELATIONSHIP AND THE MOLECULAR BASIS OF DRUG ACTION.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-IV TOXICITY SCREENING OF THERAPEUTIC DRUGS.pdf
- 复旦大学:《药物设计学》课程教学资源(虚拟实验室课外实践)Exercises for Drug Design Courses_Practice-V SYNTHESIS, LIPOPHILICITY DETERMINATION, AND QSAR STUDY OF CHALCONES AND ANALOGS WITH ANTITUMORAL ACTIVITY.pdf